AFTER securing around $15m to boost its European operations IM Cannabis has become the first Israeli company to list its shares in Canada.
International Medical Cannabis (IMC) will trade under the ticker ‘IMCC’ on the Canadian Securities Exchange and may well be the first of many Israeli companies to follow this path.
Israeli daily financial website Calcalist recently reported on an anticipated flow of domestic companies to Canada.
With cannabis being legal in Canada it affords ambitious firms proximity to some of the leading global cannabis companies and access to an established cannabis-savvy financial system.
IMC has global ambitions with an keen focus on the European market and it will use the proceeds of a successful $15m private fund-raising round to bolster its footprint in Germany, Portugal and Greece
Oren Shuster, Chief Executive Officer, said it was doing ‘exceptionally well to position the company as a market leader in the EU’.
He said its European expansion strategy includes operations in Germany, a supply agreement in Europe, and will soon include operations in Portugal and Greece
IMC says it views the German market as particularly attractive given its size, regulatory structure and proximity to Israel, and earlier this year it purchased Adjupharm a German EU-GMP manufacturer and distributor.
This business has licenses to import, export and distribute medical cannabis in Germany and has been distributing medical products to pharmacies for over 10 years, says IMC.